首页 | 本学科首页   官方微博 | 高级检索  
     


Tacrolimus in corticosteroid-resistant ulcerative colitis
Authors:Nobuyuki Matsuhashi  Atsushi Nakajima  Kiyotaka Watanabe  Yukiko Komeno  Atsushi Suzuki  Shin Ohnishi  Masao Omata  Kenji Kondo  Yoshiki Usui  Jun-ichi Iwadare  Toshiaki Watanabe  Hirokazu Nagawa  Tetsuichiro Muto
Affiliation:(1) Department of Gastroenterology, Faculty of Medicine, University of Tokyo, Tokyo, Japan, JP;(2) Department of Internal Medicine, Social Health Insurance Medical Center, Tokyo, Japan, JP;(3) Department of Colo-proctology, Social Health Insurance Medical Center, Tokyo, Japan, JP;(4) First Department of Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan, JP
Abstract:
We report a case of refractory ulcerative colitis treated with tacrolimus. The patient was a 73-year-old woman with a 45-year history of ulcerative colitis. An attack unresponsive to intravenous corticosteroid therapy occurred when she was age 73. Leukocytapheresis therapy was attempted, but was discontinued because of the patient's poor general condition. Cyclosporine A therapy brought about fair control of the disease. A liver injury that was suspected to be associated with this agent, however, occurred within 5 weeks of its initiation. At that time, the cyclosporine A was discontinued and azathioprine treatment was started. Within 6 weeks, signs of exacerbation of the ulcerative colitis became apparent. Tacrolimus administered at that time brought about remission of the disease, and the corticosteroid dose was then reduced. Tacrolimus, like cyclosporine A, appears to be effective for the treatment of attacks of ulcerative colitis. Received: August 23, 1999 / Accepted: January 28, 2000
Keywords:: ulcerative colitis  tacrolimus  cyclosporine A  immunosuppressant  Crohn's disease
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号